Scientific Programme

© Switzerland Tourism / Lorenz Richard
Beaulieu, Lausanne
Filters

Program

Filters


Thursday, August 28

09:00 – 09:45

Registration

09:45 – 09:50

Welcome

Camillo Ribi, Lausanne CH; Julia Esser-Von Bieren, Epalinges CH
09:50 – 11:00

Plenary 1

Autoimmunity

Sanjiv Luther, Epalinges ; Yannick Muller, Lausanne
Research area MIX: Fundamental & Clinical Science

Basis of autoimmune dysregulation

Carola Vinuesa, London GB

Resetting autoimmunity in immune-mediated autoimmune disease

Gerhard Krönke, Berlin DE
11:00 – 11:20

Coffee break

11:20 – 12:30

Plenary 2

Host immunity, epithelial barriers and microbiome

Isabelle Arnold Wallén, Zürich CH; Julia Esser-Von Bieren, Epalinges CH
Research area MIX: Fundamental & Clinical Science

Host immunity and the microbiome

Yasmine Belkaid, Paris FR

Modulation of human immunity by T cell cross-reactivity: from commensals to intestinal food antigens

Petra Bacher, Kiel DE
12:30 – 14:00

Lunch break

12:45 – 13:45

Guided poster tour Thursday

13:00 – 13:45

Company Symposia 1

Exploring New Horizons in Hereditary Angioedema (HAE) Treatment: Innovations and Future Perspectives

13:00 – 13:45

Company Symposia 2

Innovations in Pediatric Allergology: Newly Approved Tree Pollen and HDM AIT Therapies​​​​

14:00 – 15:30

Parallel Session 1

Allergy (respiratory)

Milena Sokolowska, Davos ; Niki Ubags, Lausanne
Research area MIX: Fundamental & Clinical Science

Epithelial Barrier Theory and the Development of Allergic, Autoimmune and Neuropsychiatric Diseases

Cezmi Akdis, Davos Wolfgang CH

Macrophage memory as a driver of type 2 inflammatory diseases

Julia Esser-Von Bieren, Epalinges CH

Location matters: defining the architecture of the bronchial wall in health and asthma

Clare Lloyd, London GB
14:00 – 15:30

Parallel Session 2

Tumor-Immunology

Denarda Dangaj, Lausanne
Research area FUN: Fundamental Science

Unveiling the Mechanisms of TIL Therapy: Toward Next-Generation Approaches

Alexandre Harari, Lausanne CH

Targeting malignant glioma immunomatrix with engineered immune cells

Denis Migliorini, Genève CH

Local mechanisms regulating anti-cancer immunity in tumors

Jan Böttcher, Tübingen DE
14:00 – 15:30

Parallel Session 3

Immune defects

Mike Recher, Basel ; Jana Pachlopnik, Zürich
Research area CLI: Clinical Science

Human ADA2 deficiency

Isabelle Meyts, Leuven BE

BMT in severe immune deficits

Tayfun Güngör, Zürich CH

Inborn errors of immunity in inflammatory bowel disease

Holm Uhlig, Oxford GB
15:30 – 16:00

Coffee break

16:00 – 17:00

Short Communication Session

Clinical Immunology & Allergy

Camillo Ribi, Lausanne CH; Gerhard Krönke, Berlin DE
Research area MIX: Fundamental & Clinical Science
16:00 – 17:00

Short Communication Session

Allergology

Sina Bohnacker, Lausanne ; Cezmi Akdis, Davos Wolfgang CH
Research area MIX: Fundamental & Clinical Science
17:00 – 17:15

Room Change

17:15 – 18:15

SSAI General Assembly